1. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Biological agents. Volume 100 B. A review of human carcinogens. IARC Monogr Eval Carcinog Risks Hum 2012; 100:1-441.
2. Kjaer SK, van den Brule AJ, Paull G, Svare EI, Sherman ME, Thomsen BL, et al. Type specific persistence of high risk human papillomavirus (HPV) as indicator of high grade cervical squamous intraepithelial lesions in young women: population based prospective follow up study. CJ BMJ. 2002; 325(7364): 572.
3. Bouvard V, Baan R, Straif K, Grosse Y, Secretan B, Ghissassi FE, et al. A review of human carcinogens – part B: biological agents. Lancet Oncol 2009; 10:321-2.
4. Practice Bulletin No. 168: Cervical Cancer Screening and Prevention. Committee on Practice Bulletins—Gynecology. Obstet Gynecol. 2016; 128: 111-30.
5. Saslow D, Solomon D, Lawson HW, Killackey M, Kulasingam SL, Cain J, et al. ACS-ASCCP-ASCP Cervical Cancer Guideline Committee. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. CA Cancer J Clin. 2012;62(3):147-72.
6. Huh WK, Ault KA, Chelmow D, Davey DD, Goulart RA, Garcia FA, et al. Use of primary high-risk human papillomavirus testing for cervical cancer screening: interim clinical guidance. J Low Genit Tract Dis. 2015; 19: 91-6.
7. Gupta S, Palmer C, Bik EM, Cardenas JP, Nuñez H, Kraal L, et al. Self-Sampling for Human Papillomavirus Testing: Increased Cervical Cancer Screening Participation and Incorporation in International Screening Programs. Front Public Health. 2018; 9; 6: 77.
8. Saslow D, Solomon D, Lawson HW, Killackey M, Kulasingam SL, Cain JM, et al. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology Screening Guidelines for the Prevention and Early Detection of Cervical Cancer. J Low Genit Tract Dis. 2012; 16: 175-204. Review.
9. Coutlée F, Rouleau D, Petignat P, Ghattas G, Kornegay JR, Schlag P, et al. Enhanced detection and typing of human papillomavirus (HPV) DNA in anogenital samples with PGMY primers and the linear array HPV genotyping test. J Clin Microbiol 2006; 44: 1998-2006.
10. González-Bosquet E, Esteva C, Muñoz-Almagro C, Ferrer P, Pérez M, Lailla JM. Identification of vaccine human papillomavirus geno-types in squamous intraepithelial lesions (CIN2-3) Gynecol Oncol. 2008; 111: 9-12.
11. Levert M, Clavel C, Graesslin O, Masure M, Birembaut P, Quereux C, et al. Human papillomavirus typing in routine cervical smears. Result from a series of 3778 patients. Gynecol Obstet Fertil. 2000; 28: 722-8.
12. Cilingir IU, Bengisu E, Ağaçfidan A, Koksal MO, Topuz S, Berkman S, et al. Microarray detection of human papilloma virus genotypes among Turkish women with abnormal cytology at a colposcopy unit. J Turk Ger Gynecol Assoc. 2013; 14: 23-7.
13. Massad LS, Einstein MH, Huh WK, Katki HA, Kinney WK, Schiffman M et al. 2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors Low Genit Tract Dis. 2013;17(5 ):1-27.
14. Wright TC, Stoler MH, Behrens CM, Sharma A, Zhang G, Wright TL. Primary cervical cancer screening with human papillomavirus: end of study results from the ATHENA study using HPV as the first-line screening test. Gynecol Oncol. 2015;136(2):189,
15. Huh WK, Ault KA, Chelmow D, Davey DD, Goulart RA, Garcia FA, et al. Use of primary high-risk human papillomavirus testing for cervical cancer screening: interim clinical guidance. Gynecol Oncol. 2015;136(2):178.
16. Einstein MH, Garcia FA, Mitchell AL, Day SP, Age-stratified performance of the Cervista HPV 16/18 genotyping test in women with ASC-US cytology. Cancer Epidemiol Biomarkers Prev. 2011;20(6):1185
17. Dursun P, Senger S, Arslan H, Kuşcu E, Ayhan A. Human papillomavirus (HPV) prevalence and types among Turkish women at a gynecology outpatient unit. BMC Infect Dis. 2009; 9: 191.
18. Gultekin M, Zayifoglu KM, Kucukyildiz I, Dundar S, Boztas G, Semra TH, et al. Initial results of population based cervical cancer screening program using HPV testing in one million Turkish women. Int J Cancer 2018; 142: 1952-8.
19. Guo Z, Jia MM, Chen Q, Chen HM, Chen PP, Zhao DM, Ren LY, Sun XB, Zhang SK.Stany MP, Bidus MA, Reed EJ, Kaplan KJ, McHale MT, Rose GS, et al. . The prevalence of HR-HPV DNA in ASC-US Pap smears: a military population study. Gynecol Oncol. 2006; 101:82-5.
20. Fakhreldin M, Elmasry K. Improving the performance of reflex Human Papilloma Virus (HPV) testing in triaging women with atypical squamous cells of undetermined significance (ASCUS): a restrospective study in a tertiary hospital in United Arab Emirates (UAE). Vaccine. 2016;34:823-30.
21. Guo Z, Jia MM, Chen Q, Chen HM, Chen PP, Zhao DM et al. Performance of Different Combination Models of High-Risk HPV Genotyping in Triaging Chinese Women With Atypical Squamous Cells of Undetermined Significance, Front Oncol. 2019; 3;9:202.
22. Cheng JX, Yao LL, Xiang H, Zhan YJ, Zhou P, Yuan M, et al. Cervical cytology ASCUS patients with HPV detection and clinical value. Clin Exp Obstet Gynecol. 2016;43(4):592-6.
23. Gök M, CoupéVM, Berkhof J, Verheijen RH, Helmerhorst TJ, Hogewoning CJ, et al. HPV16 and increased risk of recurrence after treatment for CIN. Gynecol Oncol. 2007; 104: 273.
24. Unnop J, Xavier C, Suzanne MG, Paulo N, Johanna P, Maria Rowena RR, et al. Natural History of Progression of HPV Infection to Cervical Lesion or Clearance: Analysis of the Control Arm of the Large, Randomised PATRICIA Study HPV PATRICIA Study Group PLoS One. 2013; 8: 79260.
25. Gage JC, Hanson VW, Abbey K, Dippery S, Gardner S, Kubota J, et al. ASCUS LSIL Triage Study (ALTS) Group. Number of cervical biopsies and sensitivity of colposcopy. Obstet Gynecol. 2006; 10: 264.,
26. Pretorius RG, Zhang WH, Belinson JL, Huang MN, Wu LY, Zhang X, et al. Colposcopically directed biopsy, random cervical biopsy, and endocervical curettage in the diagnosis of cervical intraepithelial neoplasia II or worse. Am J Obstet Gynecol. 2004; 191: 430.
27. Solomon D, Stoler M, Jeronimo J, Khan M, Castle P, Schiffman M. Diagnostic utility of endocervical curettage in women undergoing colposcopy for equivocal or low-grade cytologic abnormalities. Obstet Gynecol. 2007; 110: 288.